The ability to manipulate RyR2 cluster nanoscale organisation to regulate Ca2+ leak occurrence represents an intriguing potential avenue to pursue in the development of novel therapies for cardiac pathologies, in particular HF. The gene discussed is RYR2; the disease is hydrops fetalis.